The Role of Rapamycin in Healthspan Extension via the Delay of Organ Aging

Yan Zhang,Jinjin Zhang,Shixuan Wang
DOI: https://doi.org/10.1016/j.arr.2021.101376
IF: 11.788
2021-09-01
Ageing Research Reviews
Abstract:<p>Aging can not only shorten a healthy lifespan, but can also lead to multi-organ dysfunction and failure. Anti-aging is a complex and worldwide conundrum for eliminating the various pathologies of senility. The past decade has seen great progress in the understanding of the aging-associated signaling pathways and their application for developing anti-aging approaches. Currently, some drugs can improve quality of life. The activation of mammalian target of rapamycin (mTOR) signaling is one of the core and detrimental mechanisms related to aging; rapamycin can reduce the rate of aging, improve age-related diseases by inhibiting the mTOR pathway, and prolong lifespan and healthspan effectively. However, the current evidence for rapamycin in lifespan extension and organ aging is fragmented and scattered. In this review, we summarize the efficacy and safety of rapamycin in prolonging a healthy lifespan by systematically alleviating aging in multiple organ systems, i.e., the nervous, urinary, digestive, circulatory, motor, respiratory, endocrine, reproductive, integumentary and immune systems, to provide a theoretical basis for the future clinical application of rapamycin in anti-aging.</p>
cell biology,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?
The problem this paper attempts to address is the exploration of the role of Rapamycin in extending healthy lifespan and delaying organ aging. Specifically, the paper systematically summarizes the effectiveness and safety of Rapamycin in extending healthy lifespan across multiple organ systems, including the nervous system, reproductive system, urinary system, digestive system, circulatory system, musculoskeletal system, respiratory system, endocrine system, skin system, and immune system. The aim is to provide a theoretical foundation for the future clinical application of Rapamycin in the field of anti-aging. The core issues the paper focuses on are: 1. **How Rapamycin extends healthy lifespan by inhibiting the mTOR signaling pathway**: The mTOR signaling pathway is one of the core mechanisms closely related to aging. Rapamycin can slow down the aging process, improve age-related diseases, and effectively extend lifespan and healthy lifespan by inhibiting this pathway. 2. **The specific effects of Rapamycin in different organ systems**: The paper discusses in detail the role of Rapamycin in different organ systems, including its impact on neurodegenerative diseases, reproductive function decline, kidney function deterioration, liver aging, periodontal disease, and more. 3. **The safety and potential side effects of Rapamycin**: Although Rapamycin shows potential in extending healthy lifespan, its safety and potential side effects in humans still require further research. The paper discusses known toxicities and adverse reactions to provide more comprehensive information for future clinical applications. Overall, this paper aims to provide scientific evidence for the potential application of Rapamycin as an anti-aging drug and to explore its specific effects and safety in different organ systems.